RTI International: New Treatment for PTSD Shows Promise in Clinical Trial
November 06, 2019
November 06, 2019
RESEARCH TRIANGLE PARK, North Carolina, Nov. 6 -- RTI International issued the following news:
* * *
- First multi-site randomized trial shows stellate ganglion block is effective in treating PTSD symptoms in active-duty service members
* * *
A clinical trial of active-duty service members suffering from post-traumatic stress disorder (PTSD) showed that symptoms improved after receiving stellate ganglion block (SGB) injections. Results from thi . . .
* * *
- First multi-site randomized trial shows stellate ganglion block is effective in treating PTSD symptoms in active-duty service members
* * *
A clinical trial of active-duty service members suffering from post-traumatic stress disorder (PTSD) showed that symptoms improved after receiving stellate ganglion block (SGB) injections. Results from thi . . .